HLS Therapeutics Statistics

Total Valuation

TSX:HLS has a market cap or net worth of CAD 137.98 million. The enterprise value is 208.48 million.

Market Cap	137.98M
Enterprise Value	208.48M

Important Dates

The next estimated earnings date is Thursday, May 8, 2025.

Earnings Date	May 8, 2025
Ex-Dividend Date	n/a

Share Statistics

TSX:HLS has 31.79 million shares outstanding. The number of shares has decreased by -1.31% in one year.

Current Share Class	n/a
Shares Outstanding	31.79M
Shares Change (YoY)	-1.31%
Shares Change (QoQ)	-4.92%
Owned by Insiders (%)	0.68%
Owned by Institutions (%)	10.58%
Float	19.25M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.69
PB Ratio	1.34
P/TBV Ratio	n/a
P/FCF Ratio	12.01
P/OCF Ratio	11.98
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.64, with an EV/FCF ratio of 18.14.

EV / Earnings	-7.37
EV / Sales	2.56
EV / EBITDA	9.64
EV / EBIT	n/a
EV / FCF	18.14

Financial Position

The company has a current ratio of 1.57, with a Debt / Equity ratio of 0.93.

Current Ratio	1.57
Quick Ratio	1.11
Debt / Equity	0.93
Debt / EBITDA	4.42
Debt / FCF	8.32
Interest Coverage	-0.76

Financial Efficiency

Return on equity (ROE) is -23.26% and return on invested capital (ROIC) is -2.97%.

Return on Equity (ROE)	-23.26%
Return on Assets (ROA)	-2.60%
Return on Invested Capital (ROIC)	-2.97%
Return on Capital Employed (ROCE)	-5.60%
Revenue Per Employee	885,497
Profits Per Employee	-307,396
Employee Count	92
Asset Turnover	0.31
Inventory Turnover	1.58

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -10.95% in the last 52 weeks. The beta is 1.01, so TSX:HLS's price volatility has been similar to the market average.

Beta (5Y)	1.01
52-Week Price Change	-10.95%
50-Day Moving Average	4.25
200-Day Moving Average	3.74
Relative Strength Index (RSI)	48.81
Average Volume (20 Days)	14,770

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TSX:HLS had revenue of CAD 81.47 million and -28.28 million in losses. Loss per share was -0.89.

Revenue	81.47M
Gross Profit	60.37M
Operating Income	-11.06M
Pretax Income	-22.42M
Net Income	-28.28M
EBITDA	21.56M
EBIT	-11.06M
Loss Per Share	-0.89

Full Income Statement

Balance Sheet

The company has 25.12 million in cash and 95.61 million in debt, giving a net cash position of -70.49 million or -2.22 per share.

Cash & Cash Equivalents	25.12M
Total Debt	95.61M
Net Cash	-70.49M
Net Cash Per Share	-2.22
Equity (Book Value)	102.65M
Book Value Per Share	3.23
Working Capital	18.50M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 11.52 million and capital expenditures -21,583, giving a free cash flow of 11.49 million.

Operating Cash Flow	11.52M
Capital Expenditures	-21,583
Free Cash Flow	11.49M
FCF Per Share	0.36

Full Cash Flow Statement

Margins

Gross margin is 74.11%, with operating and profit margins of -13.57% and -34.71%.

Gross Margin	74.11%
Operating Margin	-13.57%
Pretax Margin	-27.52%
Profit Margin	-34.71%
EBITDA Margin	26.47%
EBIT Margin	-13.57%
FCF Margin	14.11%

Dividends & Yields

TSX:HLS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	1.31%
Shareholder Yield	1.31%
Earnings Yield	-20.50%
FCF Yield	8.33%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

TSX:HLS has an Altman Z-Score of -0.82. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.82
Piotroski F-Score	n/a